Miniatura

Fitxers

s44276-025-00157-y.pdf (723.55 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2025-06-04

Llicència de publicació

cc-by (c) Hendricks, Linda A. J. et al., 2025
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/223666

Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)—a European cohort study

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1038/s44276-025-00157-y

Resum

BackgroundPTEN hamartoma tumour syndrome (PHTS) patients have a high hereditary risk of cancer, especially breast (BC), endometrial (EC), and thyroid cancer (TC). However, the prognosis of PHTS-related cancers is unknown.MethodsThis European cohort study included adult PHTS patients with data from medical files, registries, and/or questionnaires. Overall survival (OS) was assessed using Kaplan-Meier analyses and were compared with sporadic cancer and the general population using standardized mortality (SMR) and relative survival rates (RSR). Survival bias was addressed using left-truncation.ResultsOverall, 147 BC patients were included. The 10y-OS was 77% (95%CI = 66-90), decreasing with increasing stage from 90% (95%CI = 73-100) for stage 0 to 0% (95%CI = 0-0) for stage IV. BC relative survival was comparable to sporadic BC in the first two years (2y-RSR = 1.1; 95%CI = 1.1-1.1) and increasing thereafter (5y-RSR = 1.7; 95%CI = 1.6-1.7). For TC (N = 56) and EC (N = 35), 10y-OS was 87% (95%CI = 74-100) and 64% (95%CI = 38-100), respectively. Overall and cancer-specific mortality in female PHTS patients exceeded general population rates (SMR = 3.7; 95%CI = 2.6-5.0 and SMR = 2.7; 95%CI = 1.6-4.4).ConclusionsThe prognosis of PHTS-related cancers was comparable to the general population. The higher overall mortality in PHTS patients is presumably related to their higher cancer incidence. These findings, and the high survival observed in early-stage cancer, emphasise the importance of recognising PHTS early to facilitate cancer surveillance.

Matèries

Oncologia pediàtrica, Càncer d'ovari, Oncologia

Matèries (anglès)

Tumors in children, Ovarian cancer, Oncology

Citació

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

HENDRICKS, Linda a. j., VERBEEK, Katja c. j., SCHUURS HOEIJMAKERS, Janneke h.m., PUTTER, Robin de, BREMS, Hilde, DAELE, Sien h. van, ANASTASIADOU, Violetta c., FORETOVA, Lenka, BENUSIGLIO, Patrick r., GERASIMENKO, Anna, COLAS, Chrystelle, VILLY, Marie charlotte, HOUDAYER, Claude, BRANCHAUD, Maud, HÜNEBURG, Robert, ARETZ, Stefan, JAHN, Arne, STEINKE-LANGE, Verena, INNELLA, Giovanni, TURCHETTI, Daniela, BARILI, Valeria, GENUARDI, Maurizio, PANFILI, Arianna, BALDASSARRI, Margherita, IRMEJS, Arvids, JONG, Mirjam m. de, LINKS, Thera p., LETER, Edward m., BOSCH, Daniëlle g.m., DONZE, Stephany h., POST, Rachel s. van der, MENSENKAMP, Arjen r., WESTDORP, Harm, HØBERG-VETTI, Hildegunn, TVEIT HAAVIND, Marianne, JØRGENSEN, Kjersti, MÆHLE, Lovise, BRISKEMYR, Siri, DUPONT GARCIA, Juliette, BLATNIK, Ana, BALMAÑA, Judith, TORRES, Maite, BRUNET, Joan, LLEUGER PUJOL, Roser, THAM, Emma, TISCHKOWITZ, Marc, EVANS, D.gareth, HYDER, Zerin, HOOGERBRUGGE, Nicoline, VOS, Janet r.. Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)—a European cohort study. _BJC Reports_. 2025. Vol. 3, núm. 42. [consulta: 8 de abril de 2026]. ISSN: 2688-4046. [Disponible a: https://hdl.handle.net/2445/223666]

Exportar metadades

JSON - METS

Compartir registre